Director Walsh Patrick D sells 13,973 shares (28% of holdings) for $1.13M as stock trades below 52-week highs
Patrick Walsh, a director at ANI Pharmaceuticals, sold nearly fourteen thousand shares across two transactions in May, representing roughly a quarter of his direct shareholding and reducing his position from approximately 52,400 to 38,400 shares. The sales occurred at prices slightly below the current trading level, while the stock remains notably below its 52-week high—a period in which ANI has delivered strong fundamentals, including profitable operations, double-digit annual revenue growth, and a stable valuation multiple. This is Walsh's first open-market sales activity at ANI over the filing window, following his earlier acquisition of shares through stock-based compensation. The timing and magnitude of the disposition—liquidating a meaningful stake over consecutive trading days while the company demonstrates solid financial health—merit attention to whether this reflects portfolio rebalancing or a shift in Walsh's confidence in the company's near-term prospects.